Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

BBP

Virtus LifeSci Biotech Products ETF

Jan 09 • 09:34AM ET

81.76

+0.84 1.04 %

Financial • Exchange Traded Fund • USA • NYSE

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	32.35%	Total Holdings	66	Perf Week	2.61%
Sponsor	Virtus ETF Solutions	ETF Type		Tags	equity	Return% 3Y	18.52%	AUM	44.44M	Perf Month	6.19%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	8.75%	NAV/sh		Perf Quarter	13.32%
Index	LifeSci Biotechnology Products Index	Average Maturity		Tags	biotechnology	Return% 10Y		52W High	82.80 -1.26%	Perf Half Y	31.00%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	48.65 68.06%	Perf YTD	2.31%
Active/Passive		Quant Type		Tags	-	Flows% 1M	36.17%	Volatility	1.86% 1.24%	Perf Year	33.90%
Dividend TTM	-	ESG Type		Tags	-	Flows% 3M	36.17%	ATR (14)	1.35	Perf 3Y	65.91%
Dividend Ex-Date	Dec 20, 2017	Dividend Type		Sector/Theme		Flows% YTD	0.00%	RSI (14)	58.89	Perf 5Y	51.68%
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.59	Perf 10Y	164.51%
Expense	0.79%	Growth/Value		SMA20	2.18%	Flows% 3Y		Rel Volume	1.31	Prev Close	80.92
Inverse/Leveraged		Market Cap		SMA50	4.83%	Flows% 5Y		Avg Volume	5.89K	Price	81.76
IPO	Dec 17, 2014	Option/Short	Yes / Yes	SMA200	23.19%	Trades		Volume	498	Change	1.04%

Oct-30-25 09:00AM	Biotech ETFs Hovering Around a 52-Week: Here's Why (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
01:40PM	Loading…
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.80%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)

Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

open in yahoo | open in marketwatch | open in google

BBP

Virtus LifeSci Biotech Products ETF

Upgrade your FINVIZ experience